{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T17:58:42Z","timestamp":1790531922803,"version":"4.1.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12885-016-2434-7","type":"journal-article","created":{"date-parts":[[2016,7,4]],"date-time":"2016-07-04T12:06:27Z","timestamp":1467633987000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Cetuximab-induced aseptic meningitis: case report and review of a rare adverse event"],"prefix":"10.1186","volume":"16","author":[{"given":"Christophe","family":"Maritaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Metz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil","family":"Baba-Hamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9ryam","family":"Jardin-Szucs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00ebl","family":"Deplanque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,4]]},"reference":[{"key":"2434_CR1","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1001\/jamainternmed.2014.2918","volume":"174","author":"G Moris","year":"2014","unstructured":"Moris G, Giarca-Mono JC. The challenge of drug-induce meningitis revisited. JAMA Intern Med. 2014;174:1511\u20132.","journal-title":"JAMA Intern Med"},{"key":"2434_CR2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.7326\/0003-4819-121-4-199408150-00004","volume":"121","author":"EA Sekul","year":"1994","unstructured":"Sekul EA, Cupler EJ, Dalakas MC. Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors. Ann Intern Med. 1994;121:259\u201362.","journal-title":"Ann Intern Med"},{"key":"2434_CR3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.intimp.2005.11.015","volume":"6","author":"DJ Hamrock","year":"2006","unstructured":"Hamrock DJ. Adverse events associated with intravenous immunoglobulin therapy. Int Immunopharmacol. 2006;6:535\u201342.","journal-title":"Int Immunopharmacol"},{"key":"2434_CR4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.tmrv.2013.05.004","volume":"27","author":"ER Stiehm","year":"2013","unstructured":"Stiehm ER. Adverse effects of human immunoglobulin therapy. Transfus Med Rev. 2013;27:171\u20138.","journal-title":"Transfus Med Rev"},{"key":"2434_CR5","first-page":"182","volume":"105","author":"D Mullane","year":"2012","unstructured":"Mullane D, Williams L, Merwick A, et al. Drug induced aseptic meningitis caused by intravenous immunoglobulin therapy. Ir Med J. 2012;105:182\u20133.","journal-title":"Ir Med J"},{"key":"2434_CR6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.autrev.2015.09.002","volume":"15","author":"P Cherin","year":"2016","unstructured":"Cherin P, Marie I, Michallet M, Pelus E, Dantal J, Crave JC, et al. Management of adverse events in the treatment of patients with immunoglobulin therapy: a review of evidence. Autoimmun Rev. 2016;15:71\u201381.","journal-title":"Autoimmun Rev"},{"key":"2434_CR7","first-page":"440","volume":"72","author":"CM Wiles","year":"2002","unstructured":"Wiles CM, Brown P, Chapel H, Guerrini R, Hughes RA, Martin TD, et al. Intravenous immunoglobulin in neurological disease: a specialist review. J Neurol Neurosurg Psychiatry. 2002;72:440\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2434_CR8","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1200\/JCO.2000.18.4.904","volume":"18","author":"J Baselga","year":"2000","unstructured":"Baselga J, Pfister D, Cooper MR, Cohen R, Burtness B, Boss M, et al. Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin. J Clin Oncol. 2000;18:904\u201314.","journal-title":"J Clin Oncol"},{"key":"2434_CR9","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/1078155212447973","volume":"19","author":"MK Emani","year":"2013","unstructured":"Emani MK, Zaiden Jr RA. Aseptic meningitis: a rare side effect of cetuximab therapy. J Oncol Pharm Pract. 2013;19:178\u201380.","journal-title":"J Oncol Pharm Pract"},{"key":"2434_CR10","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/annonc\/mdp382","volume":"20","author":"TM Feinstein","year":"2009","unstructured":"Feinstein TM, Gibson MK, Argiris A. Cetuximab-induced aseptic meningitis. Ann Oncol. 2009;20:1609\u201310.","journal-title":"Ann Oncol"},{"key":"2434_CR11","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jocn.2014.11.034","volume":"22","author":"A Ulrich","year":"2015","unstructured":"Ulrich A, Weiler S, Weller M, Rordorf T, Tarnutzer AA. Cetuximab induced aseptic meningitis. J Clin Neurosci. 2015;22:1061\u20133.","journal-title":"J Clin Neurosci"},{"key":"2434_CR12","first-page":"2015","volume":"12","author":"D Prasanna","year":"2015","unstructured":"Prasanna D, Elrafei T, Shum E, Strakhan M. More than a headache: a case of cetuximab-induced aseptic meningitis. BMJ Case Rep. 2015;12:2015.","journal-title":"BMJ Case Rep"},{"key":"2434_CR13","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/JTO.0b013e3181d408bc","volume":"5","author":"N Nagovskiy","year":"2010","unstructured":"Nagovskiy N, Agarwal M, Allerton J. Cetuximab-induced aseptic meningitis. J Thorac Oncol. 2010;5:751.","journal-title":"J Thorac Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2434-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T17:46:08Z","timestamp":1498326368000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-016-2434-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,4]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["2434"],"URL":"https:\/\/doi.org\/10.1186\/s12885-016-2434-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,4]]},"article-number":"384"}}